85
72
Growth Score
3 pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
216049
GeneFab specializes in contract development, manufacturing, and synthetic biology for cell and gene therapies.
- Philip Lee: Founder and Chief Executive Officer
About the Company
GeneFab operates as a contract development, manufacturing, and synthetic biology biofoundry, specializing in cell and gene therapies. Established in 2023, the company focuses on supporting the development and manufacturing processes for innovative therapies. With a team of 35 employees, GeneFab leverages its expertise in synthetic biology to offer
comprehensive solutions for the rapid fabrication of large DNA molecules, aiming to advance the field of biotechnology through its contract research, development, and manufacturing services. The company's commitment to innovation is evident in its acquisition of Senti Bio's chemistry, manufacturing, and controls (CMC) capabilities, positioning it as a key player in the biotech industry.
